no drug in the world provides meaningful cardiovascular protection after a heart attack. This is the first of its kind with no competition in a 10 billion dollar unmet market and we now completed the same dose that produced a 42 percent protection and now the 6 hour dose will reflect the upto 88 percent protection.
As CEO stated in a recent study just a 5 percent protection in a heart attack produced a 25 percent reduction in mortality.
Once Boehringer announce their results shortly in the coming days then I’ll say it that we are the holy grail drug of organ protection in trauma
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)